Cited 0 time in
Risk of Pneumonia Associated With the Use of Inhaled Corticosteroids in Asthma
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Sang-Heon | - |
| dc.date.accessioned | 2021-08-02T10:50:59Z | - |
| dc.date.available | 2021-08-02T10:50:59Z | - |
| dc.date.created | 2021-05-12 | - |
| dc.date.issued | 2019-11 | - |
| dc.identifier.issn | 2092-7355 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/12320 | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY | - |
| dc.title | Risk of Pneumonia Associated With the Use of Inhaled Corticosteroids in Asthma | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | Kim, Sang-Heon | - |
| dc.identifier.doi | 10.4168/aair.2019.11.6.760 | - |
| dc.identifier.scopusid | 2-s2.0-85075526759 | - |
| dc.identifier.wosid | 000498158000002 | - |
| dc.identifier.bibliographicCitation | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, v.11, no.6, pp.760 - 762 | - |
| dc.relation.isPartOf | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH | - |
| dc.citation.title | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH | - |
| dc.citation.volume | 11 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 760 | - |
| dc.citation.endPage | 762 | - |
| dc.type.rims | ART | - |
| dc.type.docType | Editorial Material | - |
| dc.identifier.kciid | ART002518907 | - |
| dc.description.journalClass | 1 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Allergy | - |
| dc.relation.journalResearchArea | Immunology | - |
| dc.relation.journalWebOfScienceCategory | Allergy | - |
| dc.relation.journalWebOfScienceCategory | Immunology | - |
| dc.subject.keywordPlus | BUDESONIDE-FORMOTEROL | - |
| dc.subject.keywordPlus | BIG DATA | - |
| dc.subject.keywordPlus | budesonide | - |
| dc.subject.keywordPlus | corticosteroid | - |
| dc.subject.keywordPlus | fluticasone | - |
| dc.subject.keywordPlus | asthma | - |
| dc.subject.keywordPlus | chronic obstructive lung disease | - |
| dc.subject.keywordPlus | corticosteroid therapy | - |
| dc.subject.keywordPlus | drug efficacy | - |
| dc.subject.keywordPlus | drug safety | - |
| dc.subject.keywordPlus | Editorial | - |
| dc.subject.keywordPlus | high risk patient | - |
| dc.subject.keywordPlus | human | - |
| dc.subject.keywordPlus | mortality | - |
| dc.subject.keywordPlus | pneumonia | - |
| dc.subject.keywordPlus | risk benefit analysis | - |
| dc.identifier.url | https://e-aair.org/DOIx.php?id=10.4168/aair.2019.11.6.760 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
